United Kingdom Healthcare Equipment & Supplies

Creo Medical Group PLC (CREO)

Track

Track

Creo Medical Group PLC recorded five insider trading transactions during the recent ninety-day period, all representing purchases. Executives and directors acquired shares totaling 250,000 GBP. These acquisitions occurred following the most recent results financiers, amidst a 4.5% stock price increase over the last quarter.
Ticker: CREO Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Creo Medical Group PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Peter Tracey Non-Executive Chairman Director
Transaction date
Purchase
Price
121.56
Quantity 21,664
Value £508,175
Michael Scheepers Chief Executive Officer Officer
Transaction date
Purchase
Price
214.25
Quantity 35,487
Value £4,678,403
2.9
Jonathan Hill Group Finance Director Executive Director
Transaction date
Purchase
Price
167.11
Quantity 86,805
Value £2,446,854
2.6
Jeremy Wilson Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.50
Quantity 40,000
Value £20,000
Angela Luger Senior Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.50
Quantity 30,000
Value £15,000
1.1
Kevin T. Crofton Non-Executive Chairman Director
Transaction date
Purchase
Price
0.17
Quantity 1,179,000
Value £200,607
2.2
Rachel Rees CFO Officer
Through Richard Rees, a closely affiliated person
Transaction date
Purchase
Price
0.20
Quantity 76,740
Value £15,360
2.2
Richard Rees Chief Financial Officer Officer
Transaction date
Purchase
Price
0.20
Quantity 98,000
Value £19,615
2.2
Richard Rees Chief Financial Officer Officer
Transaction date
Sale
Price
0.20
Quantity 174,740
Value £34,948
2.2
Richard Rees Chief Financial Officer Officer
Transaction date
Purchase
Price
0.24
Quantity 208,333
Value £50,000
1.1
Kevin Crofton Non-Executive Chairman Director
Transaction date
Purchase
Price
0.24
Quantity 2,916,666
Value £700,000
3.2
Luis Collantes PDMR
Transaction date
Purchase
Price
0.20
Quantity 4,442,485
Value £888,497
3.2
Ivonne Cantu Independent Non-Executive Director Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 125,000
Value £25,000
2.9
John Bradshaw Independent Non-Executive Director Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 1,265,135
Value £253,027
3.0
David Woods Chief Commercial Officer Officer
Transaction date
Purchase
Price
0.20
Quantity 415,255
Value £83,051
3.7
Professor Christopher Hancock Chief Technology Officer Officer
Transaction date
Purchase
Price
0.20
Quantity 383,171
Value £76,634
2.2
Richard Rees Chief Financial Officer Officer
Transaction date
Purchase
Price
0.20
Quantity 2,715,322
Value £543,064
1.5
Craig Gulliford Chief Executive Officer Officer
Through Kathryn Hogg, a closely affiliated person
Transaction date
Purchase
Price
0.20
Quantity 1,000,000
Value £200,000
2.5
Charles Spicer Non-Executive Chairman Director
Transaction date
Purchase
Price
0.20
Quantity 165,119
Value £33,024
2.2
Richard Rees Chief Financial Officer Officer
Transaction date
Purchase
Price
0.97
Quantity 70,000
Value £67,725
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-23 B Purchase Peter Tracey

Non-Executive Chairman

Director
21,664
121.56
£508,175 		21,664 121.56 £508,175
2026-06-23 2026-06-23 B Purchase
Michael Scheepers

Chief Executive Officer

Officer
35,487
214.25
£4,678,403 		35,487 214.25 £4,678,403
2026-06-23 2026-06-23 B Purchase
2.9
Jonathan Hill

Group Finance Director

Executive Director
86,805
167.11
£2,446,854 		86,805 167.11 £2,446,854
2026-06-23 2026-06-23 B Purchase
2.6
Jeremy Wilson

Non-Executive Director

Executive Director
40,000
0.50
£20,000 		40,000 0.50 £20,000
2026-06-23 2026-06-23 B Purchase Angela Luger

Senior Non-Executive Director

Executive Director
30,000
0.50
£15,000 		30,000 0.50 £15,000
2024-12-16 2024-12-13 B Purchase
1.1
Kevin T. Crofton

Non-Executive Chairman

Director
1,179,000
0.17
£200,607 		1,179,000 0.17 £200,607
2024-10-24 2024-10-24 B Purchase
2.2
Rachel Rees

CFO

Through Richard Rees, a closely affiliated person Officer
76,740
0.20
£15,360 		76,740 0.20 £15,360
2024-10-24 2024-10-24 B Purchase
2.2
Richard Rees

Chief Financial Officer

Officer
98,000
0.20
£19,615 		98,000 0.20 £19,615
2024-10-24 2024-10-24 S Sale
2.2
Richard Rees

Chief Financial Officer

Officer
174,740
0.20
£34,948 		174,740 0.20 £34,948
2024-10-21 2024-10-21 B Purchase
2.2
Richard Rees

Chief Financial Officer

Officer
208,333
0.24
£50,000 		208,333 0.24 £50,000
2024-10-21 2024-10-21 B Purchase
1.1
Kevin Crofton

Non-Executive Chairman

Director
2,916,666
0.24
£700,000 		2,916,666 0.24 £700,000
2023-03-13 2023-03-09 B Purchase
3.2
Luis Collantes

PDMR
4,442,485
0.20
£888,497 		4,442,485 0.20 £888,497
2023-03-13 2023-03-09 B Purchase
3.2
Ivonne Cantu

Independent Non-Executive Director

Non-Executive Director
125,000
0.20
£25,000 		125,000 0.20 £25,000
2023-03-13 2023-03-09 B Purchase
2.9
John Bradshaw

Independent Non-Executive Director

Non-Executive Director
1,265,135
0.20
£253,027 		1,265,135 0.20 £253,027
2023-03-13 2023-03-09 B Purchase
3.0
David Woods

Chief Commercial Officer

Officer
415,255
0.20
£83,051 		415,255 0.20 £83,051
2023-03-13 2023-03-09 B Purchase
3.7
Professor Christopher Hancock

Chief Technology Officer

Officer
383,171
0.20
£76,634 		383,171 0.20 £76,634
2023-03-13 2023-03-09 B Purchase
2.2
Richard Rees

Chief Financial Officer

Officer
2,715,322
0.20
£543,064 		2,715,322 0.20 £543,064
2023-03-13 2023-03-09 B Purchase
1.5
Craig Gulliford

Chief Executive Officer

Through Kathryn Hogg, a closely affiliated person Officer
1,000,000
0.20
£200,000 		1,000,000 0.20 £200,000
2023-03-13 2023-03-09 B Purchase
2.5
Charles Spicer

Non-Executive Chairman

Director
165,119
0.20
£33,024 		165,119 0.20 £33,024
2022-05-27 2022-05-26 B Purchase
2.2
Richard Rees

Chief Financial Officer

Officer
70,000
0.97
£67,725 		70,000 0.97 £67,725
Explore more

More insider trading research around Creo Medical Group PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe